291 related articles for article (PubMed ID: 27528712)
21. TRF2 promotes dynamic and stepwise looping of POT1 bound telomeric overhang.
Paul T; Liou W; Cai X; Opresko PL; Myong S
Nucleic Acids Res; 2021 Dec; 49(21):12377-12393. PubMed ID: 34850123
[TBL] [Abstract][Full Text] [Related]
22. POT1 loss-of-function variants predispose to familial melanoma.
Robles-Espinoza CD; Harland M; Ramsay AJ; Aoude LG; Quesada V; Ding Z; Pooley KA; Pritchard AL; Tiffen JC; Petljak M; Palmer JM; Symmons J; Johansson P; Stark MS; Gartside MG; Snowden H; Montgomery GW; Martin NG; Liu JZ; Choi J; Makowski M; Brown KM; Dunning AM; Keane TM; López-Otín C; Gruis NA; Hayward NK; Bishop DT; Newton-Bishop JA; Adams DJ
Nat Genet; 2014 May; 46(5):478-481. PubMed ID: 24686849
[TBL] [Abstract][Full Text] [Related]
23. Germline mutations in Protection of Telomeres 1 in two families with Hodgkin lymphoma.
McMaster ML; Sun C; Landi MT; Savage SA; Rotunno M; Yang XR; Jones K; Vogt A; Hutchinson A; Zhu B; Wang M; Hicks B; Thirunavukarason A; Stewart DR; Koutros S; Goldstein AM; Chanock SJ; Caporaso NE; Tucker MA; Goldin LR; Liu Y
Br J Haematol; 2018 May; 181(3):372-377. PubMed ID: 29693246
[TBL] [Abstract][Full Text] [Related]
24. Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy.
Herling CD; Klaumünzer M; Rocha CK; Altmüller J; Thiele H; Bahlo J; Kluth S; Crispatzu G; Herling M; Schiller J; Engelke A; Tausch E; Döhner H; Fischer K; Goede V; Nürnberg P; Reinhardt HC; Stilgenbauer S; Hallek M; Kreuzer KA
Blood; 2016 Jul; 128(3):395-404. PubMed ID: 27226433
[TBL] [Abstract][Full Text] [Related]
25. A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.
Speedy HE; Di Bernardo MC; Sava GP; Dyer MJ; Holroyd A; Wang Y; Sunter NJ; Mansouri L; Juliusson G; Smedby KE; Roos G; Jayne S; Majid A; Dearden C; Hall AG; Mainou-Fowler T; Jackson GH; Summerfield G; Harris RJ; Pettitt AR; Allsup DJ; Bailey JR; Pratt G; Pepper C; Fegan C; Rosenquist R; Catovsky D; Allan JM; Houlston RS
Nat Genet; 2014 Jan; 46(1):56-60. PubMed ID: 24292274
[TBL] [Abstract][Full Text] [Related]
26. Investigation of conformational dynamics of Tyr89Cys mutation in protection of telomeres 1 gene associated with familial melanoma.
Amir M; Ahamad S; Mohammad T; Jairajpuri DS; Hasan GM; Dohare R; Islam A; Ahmad F; Hassan MI
J Biomol Struct Dyn; 2021 Jan; 39(1):35-44. PubMed ID: 31847782
[TBL] [Abstract][Full Text] [Related]
27. Cancer chromosomes going to POT1.
Chang S
Nat Genet; 2013 May; 45(5):473-5. PubMed ID: 23619786
[TBL] [Abstract][Full Text] [Related]
28. Somatic reversion impacts myelodysplastic syndromes and acute myeloid leukemia evolution in the short telomere disorders.
Schratz KE; Gaysinskaya V; Cosner ZL; DeBoy EA; Xiang Z; Kasch-Semenza L; Florea L; Shah PD; Armanios M
J Clin Invest; 2021 Sep; 131(18):. PubMed ID: 34343137
[TBL] [Abstract][Full Text] [Related]
29. Fission yeast Pot1-Tpp1 protects telomeres and regulates telomere length.
Miyoshi T; Kanoh J; Saito M; Ishikawa F
Science; 2008 Jun; 320(5881):1341-4. PubMed ID: 18535244
[TBL] [Abstract][Full Text] [Related]
30. POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families.
Potrony M; Puig-Butille JA; Ribera-Sola M; Iyer V; Robles-Espinoza CD; Aguilera P; Carrera C; Malvehy J; Badenas C; Landi MT; Adams DJ; Puig S
Br J Dermatol; 2019 Jul; 181(1):105-113. PubMed ID: 30451293
[TBL] [Abstract][Full Text] [Related]
31. POT1-TPP1 telomere length regulation and disease.
Aramburu T; Plucinsky S; Skordalakes E
Comput Struct Biotechnol J; 2020; 18():1939-1946. PubMed ID: 32774788
[TBL] [Abstract][Full Text] [Related]
32. Genetic Variation Associated with Longer Telomere Length Increases Risk of Chronic Lymphocytic Leukemia.
Ojha J; Codd V; Nelson CP; Samani NJ; Smirnov IV; Madsen NR; Hansen HM; de Smith AJ; Bracci PM; Wiencke JK; Wrensch MR; Wiemels JL; Walsh KM;
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1043-9. PubMed ID: 27197291
[TBL] [Abstract][Full Text] [Related]
33. Impact of Gln94Glu mutation on the structure and function of protection of telomere 1, a cause of cutaneous familial melanoma.
Amir M; Ahmad S; Ahamad S; Kumar V; Mohammad T; Dohare R; Alajmi MF; Rehman T; Hussain A; Islam A; Ahmad F; Hassan MI
J Biomol Struct Dyn; 2020 Mar; 38(5):1514-1524. PubMed ID: 31014199
[TBL] [Abstract][Full Text] [Related]
34. Pathophysiology of chronic lymphocytic leukemia and human B1 cell development.
Kikushige Y
Int J Hematol; 2020 May; 111(5):634-641. PubMed ID: 31797231
[TBL] [Abstract][Full Text] [Related]
35. Lack of Mutations in POT1 Gene in Selected Families with Familial Non-Medullary Thyroid Cancer.
Orois A; Badenas C; Reverter JL; López V; Potrony M; Mora M; Halperin I; Oriola J
Horm Cancer; 2020 Apr; 11(2):111-116. PubMed ID: 32172474
[TBL] [Abstract][Full Text] [Related]
36. A novel small molecule that alters shelterin integrity and triggers a DNA-damage response at telomeres.
Rodriguez R; Müller S; Yeoman JA; Trentesaux C; Riou JF; Balasubramanian S
J Am Chem Soc; 2008 Nov; 130(47):15758-9. PubMed ID: 18975896
[TBL] [Abstract][Full Text] [Related]
37. Familial chronic lymphocytic leukemia.
Goldin LR; Slager SL; Caporaso NE
Curr Opin Hematol; 2010 Jul; 17(4):350-5. PubMed ID: 20389242
[TBL] [Abstract][Full Text] [Related]
38. Familial Clonal Hematopoiesis in a Long Telomere Syndrome.
DeBoy EA; Tassia MG; Schratz KE; Yan SM; Cosner ZL; McNally EJ; Gable DL; Xiang Z; Lombard DB; Antonarakis ES; Gocke CD; McCoy RC; Armanios M
N Engl J Med; 2023 Jun; 388(26):2422-2433. PubMed ID: 37140166
[TBL] [Abstract][Full Text] [Related]
39. Genetic variation in POT1 and risk of thyroid subsequent malignant neoplasm: A report from the Childhood Cancer Survivor Study.
Richard MA; Lupo PJ; Morton LM; Yasui YA; Sapkota YA; Arnold MA; Aubert G; Neglia JP; Turcotte LM; Leisenring WM; Sampson JN; Chanock SJ; Hudson MM; Armstrong GT; Robison LL; Bhatia S; Gramatges MM
PLoS One; 2020; 15(2):e0228887. PubMed ID: 32040538
[TBL] [Abstract][Full Text] [Related]
40. A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families.
Calvete O; Martinez P; Garcia-Pavia P; Benitez-Buelga C; Paumard-Hernández B; Fernandez V; Dominguez F; Salas C; Romero-Laorden N; Garcia-Donas J; Carrillo J; Perona R; Triviño JC; Andrés R; Cano JM; Rivera B; Alonso-Pulpon L; Setien F; Esteller M; Rodriguez-Perales S; Bougeard G; Frebourg T; Urioste M; Blasco MA; Benítez J
Nat Commun; 2015 Sep; 6():8383. PubMed ID: 26403419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
